b14, the fact they haven't issued a pr is not surprising to me only because as I posted over on the Google board, I spoke with Mike Gray last month and he told me they had no intention of issuing a press release upon the filing with the FDA. I told him how wrong I thought that was and he said he would pass it along but the earliest we would probably find out is possibly next week. He said they may be making some presentations surrounding the JP Morgan conference (but not at the conference) beginning on the 13th and they would probably be updating the slide deck which would contain updated status on 427, that is if they actually file by then. I have no idea if they filed or not and I am very ticked off they decided to keep this very material news to themselves. Please contact management and express your dissatisfaction.
maui and atpl, thanks for the information. Definitely looking forward to more information and wondering what will happen when the market opens, not that it really matters because my shares are held long term and I have no intention of selling anytime soon. This seems like it still has much more room to run. GLTA.
Silly question. Was this already known before today? I never got a chance to look at the ASH abstracts for SGEN so I don't know if this was already known and I am trying to figure out what impact if any today's news might have on trading on Monday. It sounds like very good, although early, results that will help show why we are not just Adcentris and we have a pipeline that could make SGEN stock price much higher in the months and years to come. GLTA hopefully today's PR was something new and we can get a nice pop on Monday.